Mephedrone designated Class B drug
Mephedrone and related compounds in the cathione group are now banned. Following recommendation from the Advisory Council on the Misuse of Drugs, the compounds are now classified as Class B drugs. The ban came into effect on 16 April 2010.
Advice from the Department of Health states that individuals who have taken the drug and have acute toxic effects should be referred to accident and emergency, whereas less severe problems should be managed symptomatically.
Citation: Clinical Pharmacist URI: 11009964
Recommended from Pharmaceutical Press
- Previous
- Next
Paediatric Drug Handling
Written for new pharmaceutical scientists, this book provides a background in paediatric pharmacy and a comprehensive introduction to children's medication.
£33.00Buy now
Physicochemical Principles of Pharmacy
This established textbook covers every aspect of drug properties from the design of dosage forms to their delivery by all routes to sites of action in the body.
£48.00Buy now
Prescribing Medicines for Children
Prescribing Medicines for Children is designed to improve understanding on all aspects of paediatric prescribing, from the development of suitable drugs through to their practical administration.
£60.00Buy now
Introduction to Renal Therapeutics
Introduction to Renal Therapeutics covers all aspects of drug use in renal failure. Shows the role of the pharmacist in patient care for chronic kidney disease.
£38.00Buy now
FASTtrack: Pharmacology
FASTtrack: Pharmacology is a study guide providing an account of drug action, as well as dealing with molecular pharmacology at a more advanced level.
£25.00Buy now
Print 
PDF
Have your say
For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.